KA
GILD icon

KLCM Advisors’s Gilead Sciences GILD Stock Holding History

KLCM Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238K Hold
1,708
– – 0.02% 233
2025
Q4 		$210K Sell
1,708
-150
-8% -$18.2K 0.02% 233
2025
Q3 		$206K Buy
1,858
+50
+3% +$5.68K 0.02% 161
2025
Q2 		$200K Hold
1,808
– – 0.02% 163
2025
Q1 		$203K Buy
+1,808
New +$187K 0.02% 162
2024
Q3 		– Sell
-36,203
Closed -$2.48M – 169
2024
Q2 		$2.48M Buy
+36,203
New +$2.42M 0.31% 47
2022
Q4 		– Sell
-47,240
Closed -$2.91M – 130
2022
Q3 		$2.91M Buy
47,240
+1,802
+4% +$114K 0.68% 37
2022
Q2 		$2.81M Buy
+45,438
New +$2.81M 0.63% 38

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

KLCM Advisors's GILD Position: Q1 2026 in Review

KLCM Advisors held its Gilead Sciences (GILD) position steady in Q1 2026 at 1,708 shares worth $238K. The position accounts for 0.02% of the portfolio, ranked #233.

KLCM Advisors first reported a position in GILD in Q2 2022 and has held it in 8 quarters since. The position peaked at $2.91M in Q3 2022. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • KLCM Advisors held 1,708 shares of Gilead Sciences worth $238K as of Q1 2026.
  • KLCM Advisors left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.02% of KLCM Advisors's portfolio in Q1 2026, its #233 holding.
  • KLCM Advisors first reported a position in Gilead Sciences in Q2 2022 and has held it in 8 quarters since.
  • KLCM Advisors's Gilead Sciences position peaked at $2.91M in Q3 2022.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on KLCM Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.